Revance Therapeutics, Inc. (RVNC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 09:53AM EDT. Market open.
| Previous close | 3.2900 |
| Open | 3.3000 |
| Bid | 3.2700 x 200 |
| Ask | 3.3400 x 600 |
| Day's range | 3.2100 - 3.3300 |
| 52-week range | 3.2100 - 37.9800 |
| Volume | |
| Avg. volume | 1,830,946 |
| Market cap | 343.913M |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Revance Therapeutics, Inc. (NASDAQ:RVNC) is favoured by institutional owners who hold 63% of the company
Key Insights Institutions' substantial holdings in Revance Therapeutics implies that they have significant influence...
- Insider Monkey
Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2023 Earnings Call Transcript
Revance Therapeutics, Inc. (NASDAQ:RVNC) Q4 2023 Earnings Call Transcript February 29, 2024 Revance Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2023 Financial Results and Corporate Update Conference […]
- Simply Wall St.
US$16.33: That's What Analysts Think Revance Therapeutics, Inc. (NASDAQ:RVNC) Is Worth After Its Latest Results
Revance Therapeutics, Inc. ( NASDAQ:RVNC ) investors will be delighted, with the company turning in some strong numbers...
© 2024 Yahoo. All rights reserved.